It is the best way to diagnose a deficiency accurately
Thereby, the activated azygos vein [13,14,15,16,20,22,23,24,25] (rat azygos vein partially resembles the atrial myocardium [82]) may indeed be the BPC 157 bypassing key
Dosing Phases, Titration & Cycling The documented GLOW research schedule is a three-phase frequency taper rather than a dose-size titration
doi: 10.4097/kjae.2018.71.1.12
Peptide Vials (BPC-157, 5 mg each): 8 weeks 6 vials (25.2 mg used) 12 weeks 9 vials (42 mg used) 16 weeks 12 vials (58.8 mg used) Insulin Syringes (U-100): Per week: 7 syringes (1/day) 8 weeks: 56 syringes 12 weeks: 84 syringes 16 weeks: 112 syringes Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution
Some researchers prefer this option during the initial low-dose escalation phase, then switch to a higher concentration for maintenance dosing